摘要2012年欧洲泌尿生殖放射学会(ESUR)推出了旨在规范前列腺报告的前列腺影像报告数据系统指南(prostate imaging reporting and data system,PI-RADS),并于2014年进行了修订。笔者综述了基于PI-RADS的多参数MRI在诊断前列腺移行带癌方面的研究进展。
1Siegel R,MaJ ,Zou z.? al. Cancer statistics 2014[J]. CA CancerJ Clin,2014,64(1) :9-29.
2cNealJE, Redwine EA, Freiha FS, et al. Zonal distribution of prostatic adenocarcinoma: correlation with histologic pattern and direction of spread[J]. AmJ Surg Pathol, 1988,12 (12) : 897-906.
3Hoeks CM, Hambrock T, Yakar D, et al. Transition zone prostate cancer: detection and localization with 3T multiparametric MR imaging[J]. Radiology,2013,266(l) :207-217.
4Liu X, Zhou L. Peng W, et al. Differentiation of central gland prostate cancer from benign prostatic hyperplasia using monoexponential and biexponential diffusion-weighted imaging[J]. Magn Reson lmaging,2013,31 (8): 1318-1324.
5Akin 0, Sala E, Moskowitz CS, et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging[J]. Radiology,2006,239(3) :784-792.
6Li H, Sugirnura K, Kaji Y, et al. Conventional MRl capabilities in the diagnosis of prostate cancer in the transition zone[J]. AJR, 2006,186(3):729-742.
7Turkbey B,Choyke PL. Multiparametric MRl and prostate cancer diagnosis and risk stratification[J]. Curr Opin Urol , 2012,22 (4): 310-315.
8JE M. Regional morphology and pathology of the prostate[J]. AmJ Clin Pathol,1968,49(3) :347-357.
9JE M. Architecture of the glandular prostate. Mills SE. Histology for pathologists[M]. New York: Lippincott Williams, 1992:753.
10Vargas HA,Akin Ov Franiel T,et al. Normal central zone of the prostate and central zone involvement by prostate cancer: clinical and MR imaging implications[J]. Radiology, 2012,262 (3) : 894- 902.
4Ren J, Yang Y, Zhang J, et al. T(2)-weighted combined with diffusion-weighted images for evaluating prostatic transition zone tumors at 3 Tesla[J]. Future Oncol, 2013, 9(4): 585-593.
5Maas MC, Futterer JJ, Scheenen TW. Quantitative evaluation of computed high B value diffusion-weighted magnetic resonance imaging of the prostate[J]. Invest Radiol, 2013, 48( 11): 779-786.
6Macura KJ. Multiparametric magnetic resonance imaging of the prostate: current status in prostate cancer detection, localization, and staging[J]. Semin Roentgenol, 2008, 43(4): 303-313.
7Jacobs MA, Pan L, Macura KJ. Whole-body diffusion-weighted and proton imaging: a review of this emerging technology for monitoring metastatic cancer[J]. Semin Roentgenol, 2009, 44(2): 111-122.
8Jacobs MA, Ouwerkerk R, Kamel L, et al. Proton, diffusion-weighted imaging, and sodium (23Na) MRI of uterine leiomyomata after MR- guided high-intensity focused ultrasound: a preliminary study[J]. J Magn Reson Imaging, 2009, 29(3): 649-656.
9Desouza NM, Reinsberg SA, Scurr ED, et al. Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules[J]. Br J Radiol, 2007, 80(950): 90-95.
10Kim CK, Choi D, Park BK, et al. Diffusion-weighted Mr imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results[J]. J Magn Reson Imaging, 2008, 28(4): 963-969.
